Follow
Mahmoud Mirmehrabi, PhD, PEng
Mahmoud Mirmehrabi, PhD, PEng
President
Verified email at solidstatepharma.com - Homepage
Title
Cited by
Cited by
Year
Aminodifluorosulfinium Salts: Selective Fluorination Reagents with Enhanced Thermal Stability and Ease of Handling,
A L’Heureux, F Beaulieu, C Bennett, DR Bill, S Clayton, F LaFlamme, ...
The Journal of Organic Chemistry 75 (10), 3401-3411, 2010
3582010
Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms
M Mirmehrabi, S Rohani, KSK Murthy, B Radatus
International journal of pharmaceutics 282 (1-2), 73-85, 2004
862004
Characterization of tautomeric forms of ranitidine hydrochloride: thermal analysis, solid-state NMR, X-ray
M Mirmehrabi, S Rohani, KSK Murthy, B Radatus
Journal of crystal growth 260 (3-4), 517-526, 2004
822004
An approach to solvent screening for crystallization of polymorphic pharmaceuticals and fine chemicals
M Mirmehrabi, S Rohani
Journal of pharmaceutical sciences 94 (7), 1560-1576, 2005
772005
Thermodynamic modeling of activity coefficient and prediction of solubility: Part 2. Semipredictive or semiempirical models
M Mirmehrabi, S Rohani, L Perry
Journal of pharmaceutical sciences 95 (4), 798-809, 2006
602006
Measurement and prediction of the solubility of stearic acid polymorphs by the UNIQUAC equation
M Mirmehrabi, S Rohani
The Canadian Journal of Chemical Engineering 82 (2), 335-342, 2004
432004
Polymorphic behavior and crystal habit of an anti-viral/HIV drug: Stavudine
M Mirmehrabi, S Rohani, KSK Murthy, B Radatus
Crystal growth & design 6 (1), 141-149, 2006
412006
Supercritical carbon dioxide for pharmaceutical co-crystal production
L MacEachern, A Kermanshahi-pour, M Mirmehrabi
Crystal Growth & Design 20 (9), 6226-6244, 2020
272020
Polymorphic generation through solvent selection: ranitidine hydrochloride
M Trifkovic, S Rohani, M Mirmehrabi
Organic process research & development 11 (1), 138-143, 2007
242007
Improving the filterability and solid density of ranitidine hydrochloride form 1
M Mirmehrabi, S Rohani, KSK Murthy, B Radatus
Journal of pharmaceutical sciences 93 (7), 1692-1700, 2004
202004
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2, 4, 5-trimethyl-3, 6-dioxocyclohexa-1, 4-dienyl) butanamide
P Mollard, CR Cornell, KE Wesson, P Giannousis, S Suchit, M Mirmehrabi
US Patent 10,251,847, 2019
182019
Virtual multicomponent crystal screening: Hydrogen bonding revisited
S Ahmadi, PK Mondal, Y Wu, W Gong, M Mirmehrabi, S Rohani
Crystal Growth & Design 21 (10), 5862-5872, 2021
152021
Methods for chiral resolution of trolox
P Mollard, P Giannousis, M Mirmehrabi, H Alite, A Singh
US Patent App. 15/536,514, 2018
152018
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi
US Patent 8,022,216, 2011
152011
Stavudine
M Mirmehrabi, S Rohani, MC Jennings
Acta Crystallographica Section C: Crystal Structure Communications 61 (12 …, 2005
152005
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-buteramide and crystalline forms thereof
Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi
US Patent 8,394,959, 2013
132013
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi
US Patent 8,173,814, 2012
122012
Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
S Deshmukh, M Mirmehrabi
US Patent App. 11/634,694, 2007
122007
Maleate salts of (E)-N-{4-[3-Chloro-4-(2-pyridinylmethoxy) anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
Q Lu, MS Ku, W Chew, G Cheal, AF Hadfield, M Mirmehrabi
US Patent 9,139,558, 2015
112015
Transformation under pressure: Discovery of a novel crystalline form of anthelmintic drug Praziquantel using high-pressure supercritical carbon dioxide
L MacEachern, A Kermanshahi-Pour, M Mirmehrabi
International Journal of Pharmaceutics 619, 121723, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20